61. 自己免疫性溶血性貧血 Autoimmune hemolytic anemia Clinical trials / Disease details

臨床試験数 : 146 / 薬物数 : 131 - (DrugBank : 59) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 158

20 trials found

diseases per page:

Showing 1 to 10 of 20 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT2031210392	07/12/2021	27/10/2021	Sutimlimab (BIVV009) for the adult participants with cold agglutinin disease (CAD) who have complete ...	An open-label study for sutimlimab in participants with cold agglutinin disease (CAD) who have compl ...	Cold Agglutinin Disease	Drug: sutimlimab(BIVV009) Pharmaceutical Form: solution for injection, Route of Administration: intra ...	Tanaka Tomoyuki	NULL	Not Recruiting	>= 20age old	Not applicable	Both	7	Phase 3	Japan
2	NCT05132127 (ClinicalTrials.gov)	November 11, 2021	11/11/2021	Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Complete ...	An Open-label Study for Sutimlimab in Participants With Cold Agglutinin Disease (CAD) Who Have Compl ...	Cold Agglutinin Disease	Drug: sutimlimab	Sanofi	NULL	Completed	20 Years	N/A	All	7	Phase 3	Japan
3	EUCTR2017-003538-10-NL (EUCTR)	03/09/2018	18/12/2017	Open-Label with BIVV009 in patients with Cold Agglutinin Disease	A PIVOTAL, OPEN-LABEL, MULTICENTER STUDY TO ASSESS THEEFFICACY AND SAFETY OF BIVV009IN PATIENTS WITH ...	Primary Cold Agglutinin Disease MedDRA version: 20.0;Level: PT;Classification code 10073785;Term: Au ...	Product Name: BIVV009 Product Code: BIVV009 INN or Proposed INN: BIVV009 Other descriptive name: COMPLE ...	Bioverativ USA, Inc.	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 3	United States;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;France;Hungary;Canada;Poland;Bel ...
4	EUCTR2017-003539-12-NL (EUCTR)	03/09/2018	19/12/2017	A study to determine the safety and effectiveness of study drug BIVV009in patients with Primary Aggl ...	A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF B ...	Primary Cold Agglutinin Disease MedDRA version: 20.0;Level: PT;Classification code 10073785;Term: Au ...	Product Name: BIVV009 Product Code: BIVV009 INN or Proposed INN: BIVV009 Other descriptive name: TNT009 ...	Bioverativ USA Inc.	NULL	Not Recruiting			Female: yes Male: yes	40	Phase 3	United States;Spain;Austria;Israel;United Kingdom;Italy;France;Canada;Belgium;Australia;Netherlands; ...
5	EUCTR2017-003539-12-IT (EUCTR)	19/03/2018	15/01/2021	A study to determine the safety and effectiveness of study drug BIVV009in patients with Primary Aggl ...	A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF B ...	Primary Cold Agglutinin Disease MedDRA version: 20.0;Level: PT;Classification code 10073785;Term: Au ...	Product Name: BIVV009 Product Code: BIVV009 INN or Proposed INN: BIVV009 Other descriptive name: TNT009 ...	BIOVERATIV THERAPEUTICS INC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 3	United States;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;France;Hungary;Canada;Poland;Bel ...
6	NCT03347422 (ClinicalTrials.gov)	March 17, 2018	16/11/2017	A Study to Assess the Efficacy and Safety of BIVV009(Sutimlimab) in Participants With Primary Cold A ...	A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of S ...	Cold Agglutinin Disease	Drug: sutimlimab (BIVV009);Drug: placebo	Bioverativ, a Sanofi company	NULL	Completed	18 Years	N/A	All	42	Phase 3	United States;Australia;Austria;Belgium;Canada;France;Germany;Israel;Italy;Japan;Netherlands;Norway; ...
7	EUCTR2017-003538-10-IT (EUCTR)	07/03/2018	28/01/2021	Open-Label with BIVV009 in patients with Cold Agglutinin Disease	A PHASE 3, PIVOTAL, OPEN-LABEL, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF BIVV009IN PAT ...	Primary Cold Agglutinin Disease MedDRA version: 20.0;Level: PT;Classification code 10073785;Term: Au ...	Product Name: BIVV009 Product Code: BIVV009 INN or Proposed INN: BIVV009 Other descriptive name: TNT009 ...	BIOVERATIV THERAPEUTICS INC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 3	United States;Spain;Austria;Israel;United Kingdom;Italy;France;Canada;Belgium;Australia;Germany;Neth ...
8	NCT03347396 (ClinicalTrials.gov)	March 5, 2018	16/11/2017	A Study to Assess the Efficacy and Safety of BIVV009(Sutimlimab) in Participants With Primary Cold A ...	A Phase 3, Pivotal, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sutimlimab in ...	Agglutinin Disease, Cold	Drug: Sutimlimab	Bioverativ, a Sanofi company	NULL	Completed	18 Years	N/A	All	20	Phase 3	United States;Australia;Austria;Belgium;Canada;France;Germany;Israel;Italy;Japan;Netherlands;Norway; ...
9	EUCTR2017-003539-12-GB (EUCTR)	26/02/2018	23/10/2017	A study to determine the safety and effectiveness of study drug BIVV009in patients with Primary Aggl ...	A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF B ...	Primary Cold Agglutinin Disease MedDRA version: 20.0;Level: PT;Classification code 10073785;Term: Au ...	Product Name: BIVV009 Product Code: BIVV009 INN or Proposed INN: BIVV009 Other descriptive name: TNT009 ...	Bioverativ USA, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 3	United States;Spain;Austria;Israel;Switzerland;United Kingdom;Italy;France;Hungary;Canada;Poland;Bel ...
10	EUCTR2017-003538-10-GB (EUCTR)	26/02/2018	23/10/2017	Open-Label with BIVV009 in patients with Cold Agglutinin Disease	A PHASE 3, PIVOTAL, OPEN-LABEL, MULTICENTER STUDY TO ASSESS THEEFFICACY AND SAFETY OF BIVV009IN PATI ...	Primary Cold Agglutinin Disease MedDRA version: 20.0;Level: PT;Classification code 10073785;Term: Au ...	Product Name: BIVV009 Product Code: BIVV009 INN or Proposed INN: BIVV009 Other descriptive name: TNT009 ...	Bioverativ a Sanofi Company Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 3	United States;Spain;Austria;Israel;Switzerland;United Kingdom;Italy;France;Hungary;Canada;Poland;Bel ...

First Previous1 2Next Last